Molecular Docking Study Of Some Phytoconstituents Of Alangium Salviifolium Against Colorectal Cancer
Abstract
The prevalence of unpleasant effects linked to commercially accessible cancer drugs is on the rise, prompting the utilization of natural items to mitigate these symptoms. This experiment utilized the constituents of Alangium salviifolium. Plants contain alkaloids such as beta-carboline harmaline and deoxytubulosine, which has anticancer properties. The alkaloids' anticancer characteristics were analyzed using CADD, a computational design technique. The NPACT database was used to analyze the anticancer properties of the compounds, and the Auto Dock program was employed to do a binding affinity analysis with six different receptors. The outcomes were exhibited in Discovery Studio. The commonly employed pharmaceutical Paclitaxel was utilized to evaluate these results. The addition of zinc oxide to the compounds was made in order to enhance the advantages. The PyRx software was utilized to manipulate the findings of the molecular docking investigation, which were subsequently displayed in Discovery Studio. In order to conduct a pharmacokinetics study using the pkCSM database, it is necessary to validate the beta-carboline harmaline in vitro.
References
2. Surana KR, Ahire ED, Sonawane VN, Talele SG. Biomolecular and molecular docking: A modern tool in drug discovery and virtual screening of natural products. InApplied Pharmaceutical Practice and Nutraceuticals. Apple Academic Press, 2021: 209-223.
3. Surana KR, Ahire ED, Sonawane VN, Talele SG, Talele GS. Informatics and methods in nutrition design and development. InNatural Food Products and Waste Recovery. Apple Academic Press. 2021: 33-49.
4. Saleem A, Younas U, Bukhari SM, Zaidi A, Khan S, Saeed Z, Pervaiz M, Muhammad G, Shaheen S. Antioxidant and cytotoxic activities of different solvent fractions from Murraya koenigii shoots: HPLC quantification and molecular docking of identified phenolics with anti-apoptotic proteins. Bulletin of the Chemical Society of Ethiopia. 2022; 36: 651-66.
5. Pandya PN, Kumar SP, Bhadresha K, Patel CN, Patel SK, Rawal RM, Mankad AU. Identification of promising compounds from curry tree with cyclooxygenase inhibitory potential using a combination of machine learning, molecular docking, dynamics simulations and binding free energy calculations. Molecular Simulation. 2020; 46: 812-22.
6. Ahmad, Mohd F., Ahmad, S. M., Keservani, Raj K., Sharma, Anil K. A Study on Anti-Inflammatory Activity of Tuber Extracts of Solanum Tuberosum (Solanaceae) in Male Albino Rats, Nat. Aca. Sci. Lett. India. 2016; 39 (6): 421-425.
7. Keservani, Raj K., Sharma, Anil K., Jarouliya, U., Singh, A.K. Ebola Virus Disease and its Complications Universal Journal of Pharmaceutical Research, 2016c, 1 (1), 54-58.
8. Keservani, Raj K., Kesharwani, Rajesh K., Sharma, Anil K., Naturally Occurring Toxicants as Etiologic Agents of Food-borne Disease, In: Food Toxicology, Edited by Bagchi, Debasis., Swaroop, Anand, CRC Press, Taylor and Francis. Chapter 12, 2016d; 245-262. ISBN: 9781498708746
9. Ahmad, Mohd F., Ahmad, S. M., Keservani, Raj K., Pradhan, A. “Anti-Ulcer Activity of Tuber Extracts of Solanum Tuberosum (Solanaceae) In Rats", Acta Fac. Pharm. Univ. Comen. LXII, 2015a; (2): 32-37.
10. Jarouliya, U., Zacharia, A., Keservani, Raj K., Prasad, Godavarthi B.K.S. Protective effect of Spirulina maxima against fructose induced oxidative stress in Wistar rats with histopathological observations. Acta Fac. Pharm. Univ. Comen. LXII, 2015; (2): 13-19.
11. Ahmad, Mohd F., Keservani, Raj K., Babu, DJM., Interaction study between Ocimum sanctum and Glimepiride (sulfonylurea derivative) in diabetic rats, J. Chin. Pharm. Sci. 2015b;, 24 (3), 156–163.
12. Pathan AS, Jain PG, Mahajan AB, Kumawat VS, Ahire ED, Surana KR, Rajora AK, Rajora MA. Beneficial Effects of Water‐Soluble Vitamins in Nutrition and Health Promotion. Vitamins as Nutraceuticals: Recent Advances and Applications. 2023: 235-51.
13. Surana KR, Ahire ED, Sonawane VN, Talele SG, Talele GS. Molecular modeling: Novel techniques in food and nutrition development. InNatural Food Products and Waste Recovery. Apple Academic Press. 2021: 17-31).
14. Karthic A, Kesarwani V, Singh RK, Yadav PK, Chaturvedi N, Chauhan P, Yadav BS, Kushwaha SK. Computational analysis reveals monomethylated triazolopyrimidine as a novel inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp). Molecules. 2022; 27: 801.
15. Mondal P, Natesh J, Salam AA, Meeran SM. Mahanimbine isolated from Murraya koenigii inhibits P-glycoprotein involved in lung cancer chemoresistance. Bioorganic Chemistry. 2021; 129: 106170.
16. Kaloni D, Chakraborty D, Tiwari A, Biswas S. In silico studies on the phytochemical components of Murraya koenigii targeting TNF-α in rheumatoid arthritis. Journal of Herbal Medicine. 2020; 24: 100396.
17. Iman V, Mohan S, Abdelwahab SI, Karimian H, Nordin N, Fadaeinasab M, Noordin MI, Noor SM. Anticancer and anti-inflammatory activities of girinimbine isolated from Murraya koenigii. Drug design, development and therapy. 2016: 103-21.
18. Ahire ED, Surana KR, Patil CD, Shah HS, Sonwane GB, Talele SG. Role of omega-3 fatty acids in different neurodegenerative disorders. InApplied Pharmaceutical Science and Microbiology. Apple Academic Press. 2020: 173-194.
19. Mathivadani V, Smiline Girija AS, Priyadharsini JV. Targeting Epstein-Barr virus nuclear antigen 1 (EBNA-1) with Murraya koengii bio-compounds: An in-silico approach. Acta virologica. 2020; 64.
20. Gaikwad J, Jogdand S, Pathan A, Mahajan A, Darak A, Ahire ED, Surana KR. Nutraceuticals Potential of Fat‐Soluble Vitamins. Vitamins as Nutraceuticals: Recent Advances and Applications. 2023:107-28.
21. Keservani RK, Sharma AK, Kesharwani RK, editors. Nutraceuticals and dietary supplements: Applications in health improvement and disease management. CRC Press. 2020.
22. Mondal P, Natesh J, Penta D, Meeran SM. Extract of Murraya koenigii selectively causes genomic instability by altering redox-status via targeting PI3K/AKT/Nrf2/caspase-3 signaling pathway in human non-small cell lung cancer. Phytomedicine. 2022; 104: 154272.
23. Surana KR, Mahajan SK. In silico Study of Chromane Ring Compound Rubranonoside from Plumeria rubra as Anticancer Potential. Trends in Sciences. 2022; 19: 3305.
24. Ghasemzadeh A, Jaafar HZ, Rahmat A, Devarajan T. Evaluation of bioactive compounds, pharmaceutical quality, and anticancer activity of curry leaf (Murraya koenigii L.). Evidence-based complementary and alternative medicine. 2014: 2014.
25. Maheswari KU, Sankar S. In Silico Molecular Docking of Phytochemicals of Murraya koenigii Against Streptococcus mutans. Cureus. 2024; 16.
26. Ahmadipour F, Noordin MI, Mohan S, Arya A, Paydar M, Looi CY, Keong YS, Siyamak EN, Fani S, Firoozi M, Yong CL. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44+/CD24−/low): an in vitro study. Drug design, development and therapy. 2015:1193-208.
27. Kamalidehghan B, Ghafouri-Fard S, Motevaseli E, Ahmadipour F. Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng. Drug design, development and therapy. 2018:1119-33.
28. El-Shiekh RA, Kassem HA, Khaleel AE, Abd El-Mageed MM. Anticholinesterases activity of Murraya koenigii (L.) Spreng. and Murraya paniculata (L.) Jacq. essential oils with GC/MS analysis and molecular docking. Natural Product Research. 2023: 1-5.
29. Mohan S, Abdelwahab SI, Cheah SC, Sukari MA, Syam S, Shamsuddin N, Rais Mustafa M. Apoptosis effect of girinimbine isolated from Murraya koenigii on lung cancer cells in vitro. Evidence-Based Complementary and Alternative Medicine. 2013; 2013.
30. Iman V, Karimian H, Mohan S, Hobani YH, Noordin MI, Mustafa MR, Noor SM. In vitro and in vivo anti-angiogenic activity of girinimbine isolated from Murraya koenigii. Drug design, development and therapy. 2015: 1281-92.
31. Parkhe AG, Surana KR, Ahire ED, Mahajan SK, Patil DM, Sonawane DD. Impact of Vitamins on immunity. Vitamins as Nutraceuticals: Recent Advances and Applications. 2023: 87-106.
32. Patel OP, Arun A, Singh PK, Saini D, Karade SS, Chourasia MK, Konwar R, Yadav PP. Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells. European journal of medicinal chemistry. 2019; 1: 167:226-44.
33. Sharma AK, Keservani RK, Kesharwani RK, editors. Nanobiomaterials: applications in drug delivery. CRC Press; 2018.
34. RK, Sharma AK, Kesharwani RK, editors. Nanocarriers for brain targeting: principles and applications. CRC Press; 2019.
35. Pakrashy S, Mandal PK, Dey SK, Choudhury SM, Alasmary FA, Almalki AS, Islam MA, Dolai M. Design of a Structurally Novel Multipotent Drug Candidate by the Scaffold Architecture Technique for ACE-II, NSP15, and Mpro Protein Inhibition: Identification and Isolation of a Natural Product to Prevent the Severity of Future Variants of Covid 19 and a Colorectal Anticancer Drug. ACS omega. 2022; 7: 33408-22.